Titration Target for Chinese Type 2 Diabetes Mellitus Patients Using Insulin Glargine to Achieve Glycaemic Goals: An Assessment of Three Different Fasting Plasma Glucose Targets - BEYOND III/FPG GOAL Study
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2017
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms BEYOND III/FPG GOAL
- Sponsors Sanofi
- 24 Nov 2017 Planned End Date changed from 26 Apr 2018 to 4 May 2018.
- 24 Nov 2017 Planned primary completion date changed from 26 Apr 2018 to 4 May 2018.
- 31 Aug 2017 Planned End Date changed from 30 Mar 2018 to 26 Apr 2018.